You searched for : 'Q'

SAQUINAVIR DESCRIPTION FORTOVASE brand of saquinavir is an inhibitor of the human immunodeficiency virus (HIV) protease. FORTOVASE is available as beige, opaque, soft gelatin capsules for oral administration in a 200-mg strength (as saquinavir free base). Each capsule also contains the inactive ingredients medium chain mono- and diglycerides, povidone and dl-alpha tocopherol. Each capsule shell contains gelatin and glycerol 85% with the following colorants: red iron oxide, yellow iron oxide…

SAFE TUSSIN 30 LIQUID Indications And Clinical Uses: For temporary relief of cough due to minor throat and cough associated with the common cold or inhaled irritants. Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus. DIRECTIONS Adults and children 12 years of age and over: 2 teaspoonfuls every 6 hours, not to exceed 8 teaspoonfuls in 24 hours. Children 6 to under…

RHINOCORT® AQUA Astra Budesonide Glucocorticosteroid Action And Clinical Pharmacology: Budesonide is a potent nonhalogenated synthetic glucocorticosteroid with strong topical and weak systemic effects. Budesonide has a high topical anti-inflammatory potency and it is rapidly biotransformed in the liver. This favorable separation between topical anti-inflammatory activity and systemic effect is due to strong glucocorticosteroid receptor affinity and an effective first pass metabolism with a short half-life. The mechanism of action of…

REQUIP™ SmithKline Beecham Ropinirole HCl Antiparkinsonian Agent – Dopamine Agonist Action And Clinical Pharmacology: Ropinirole is a non-ergoline dopamine agonist, which activates postsynaptic dopamine receptors. In vitro studies have shown that ropinirole binds with high affinity to cloned human D2, D3, and D4 receptors. The antiparkinson activity of ropinirole is believed to be due to its stimulatory effects on central postsynaptic dopamine D2 receptors within the caudate-putamen. Ropinirole is a…

QUINTASA® Ferring 5-Aminosalicylic Acid Lower Gastrointestinal Anti-inflammatory Action And Clinical Pharmacology: 5-aminosalicylic acid (5-ASA) has been recognized as the therapeutically active moiety of sulfasalazine, a drug used to treat inflammatory bowel disease. 5-ASA has in vitro and in vivo pharmacologic effects that decrease leukotriene production, scavenge for free radicals and inhibit leukocyte chemotaxis. While its exact mode of action is currently unknown, any of these biochemical mechanisms may play a…

QUIBRON®-T QUIBRON®-T/SR Bristol Theophylline Bronchodilator Action And Clinical Pharmacology: Theophylline is a xanthine derivative structurally related to theobromine and caffeine. It has 2 distinct actions in the airways of patients with reversible obstruction: smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., nonbronchodilator prophylactic effects). While its mechanisms of action are not known with certainty, studies in animals suggest that theophylline bronchodilation is…

QUESTRAN® QUESTRAN® LIGHT Bristol Cholestyramine Resin Antidiarrheal – Antihypercholesterolemic Action And Clinical Pharmacology: Cholestyramine is a quarternary ammonium anion exchange resin with a polystyrene polymer skeleton. As the chloride salt, it binds bile acids both in vitro and in vivo, exchanging chloride for bile acid. Cholesterol is probably the sole precursor of bile acids. During normal digestion, bile acids are secreted into the intestines. A major portion of the bile…

QUINATE Rougier Quinidine Gluconate Antiarrhythmic Agent Action And Clinical Pharmacology: Quinidine depresses excitability, conduction velocity and contractility of most cardiac tissues by a direct action on cardiac cells. Indirectly, cardiac tissues will also be affected by the anticholinergic and a-adrenoceptor blocking properties of quinidine. According to Vaughan Williams-Harrison antiarrhythmic drug classification, quinidine is a Class IA agent. Thus, quinidine reduces the maximal rate of phase 0 depolarization, prolongs repolarization and…

QUINIDINE SULFATE Glaxo Wellcome Antiarrhythmic Pharmacology: Quinidine depresses excitability, conduction velocity and contractility of most cardiac tissues by a direct action on cardiac cells. Indirectly, cardiac tissues will also be affected by the anticholinergic and a-adrenoceptor blocking properties of quinidine. According to Vaughan Williams’ antiarrhythmic drug classification, quinidine is a Class 1A agent. Thus, quinidine reduces the maximal rate of phase 0 depolarization, prolongs repolarization and refractory periods and, in…

QUINIDINE General Monograph, Quinidine Antiarrhythmic – Antimalarial Action And Clinical Pharmacology: Quinidine is a class IA antiarrhythmic agent according to the Vaughan-Williams classification. It depresses most cardiac tissues by a direct action on cardiac cells. Quinidine depresses the rapid inward depolarizing sodium current, thereby reducing the amplitude of the action potential without affecting the resting potential. The slope of the slow depolarization phase of Purkinje fibres is reduced, and the…